Tech expert Trevor Long discusses Samsung’s “remarkable” seventh generation of their foldable smartphone range. “The fold ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

It’s been one year since HBO aired its groundbreaking docuseries Quiet on Set: The Dark Side of Kids TV. Child stars of the 1990s like Drake Bell spoke openly about the abuse they suffered at ...

Patients taking semaglutide, the active ingredient in Ozempic, were less likely to develop Alzheimer’s. Randomized clinical trials are needed to pin down the exact cause of this difference in risk.

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

(RTTNews) - Novo Nordisk (NVO) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion to update the Ozempic (once ...

Wegovy and Ozempic are costly and have been driving up Medi-Cal spending. The governor's office says scaling back coverage for these drugs would save the state up to $680 million by 2029.